バイエルの概要
Names, Facts, Figures about Bayer
Bayer is a Life Science company with a more than 160-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Organization chart with management structure and fields of activity (PDF, 384 KB)
バイエルのビジネス拠点は、ヨーロッパ・中東・アフリカ地域、アジア太平洋地域、北米地域、南米地域に広がり、本社はドイツのレバクーゼンにあります。各国のウェブサイトで現地情報をご覧いただけます。
The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.
コンシューマーヘルス部門は 主に一般薬(市販薬)を取り扱っており、皮膚疾患薬、栄養補助食品、鎮痛剤、胃腸薬、風邪薬、アレルギー薬、鼻炎・インフルエンザ薬を含みます。
The Crop Science Division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture.
The Enabling Functions operate as Group-wide competence centers in which business support services are bundled.
Dual governance system with the following governance bodies:
| Board of Management: | six members, Chairman: Bill Anderson |
| Supervisory Board: | 20 members, Chairman: Prof. Dr. Norbert Winkeljohann |
Locations
The Bayer Group comprises 354 consolidated companies
Our Employees
On December 31, 2023, Bayer employed 99,723 people worldwide.
Employees by Region and Gender in 2023
バイエルは、革新的な製品を通じて医療と食糧へのアクセス向上に取り組んでいます。私たちの製品は、疾患の予防、緩和、治療により、人々のクオリティ・オブ・ライフ(QOL)を高め、さらに高品質の食糧、飼料、および植物由来原料の十分な供給確保に貢献しています。
バイエルの広範囲にわたる製品ポートフォリオには、多くの世界的に有名なブランドが含まれています。
バイエルの社員データ
2023年12月31日時点で、バイエルは全世界で99,723人の社員を雇用していました。
Read more about working at Bayer
Jobs and Career
Bayer Stock
- included in nearly all the major share indices
- traded on all German stock exchanges
- dividend per share proposed to €2.4 (2022)
Bayer Group Key Data | |||
|---|---|---|---|
Bayer Group | 2021 | 2022 | Change |
| € million | € million | % |
Sales | 44,081 | 50,739 | 15.10 |
EBIT1 | 3,353 | 7,012 | 109.13 |
EBIT before special items2 | 7,295 | 9,257 | 26.90 |
EBITDA3 | 6,409 | 13,515 | 110.88 |
EBITDA before special items2 | 11,179 | 13,513 | 20.88 |
EBITDA margin before special items (in %)4 | 25.4 | 26.6 | 4.72 |
Income before income taxes | 2,046 | 4,670 | 128.25 |
Net income | 1,000 | 4,150 | 315.00 |
Earnings per share (€)5 | 1.02 | 4.22 | 313.73 |
Core earnings per share (€)6 | 6.51 | 7.94 | 21.97 |
Net financial debt | 33,137 | 31,809 | -4.01 |
Capital expenditures as per segment table | 3,004 | 3,639 | 21.14 |
Research and development expenses | 5,412 | 6,572 | 21.43 |
Dividend per Bayer AG share (€) | 2.00 | 2.4 | 20.00 |
figures restated | |||